Symbols / SENS Stock $7.30 -1.75% Senseonics Holdings, Inc.
SENS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteSenseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-05-12 | main | HC Wainwright & Co. | Buy → Buy | $14 |
| 2026-05-11 | main | Stifel | Hold → Hold | $8 |
| 2025-11-06 | main | HC Wainwright & Co. | Buy → Buy | $19 |
| 2025-11-05 | main | TD Cowen | Buy → Buy | $15 |
| 2025-11-05 | main | Barclays | Overweight → Overweight | $31 |
| 2025-08-27 | init | Barclays | — → Overweight | $2 |
| 2025-07-15 | init | TD Cowen | — → Buy | $1 |
| 2025-07-08 | main | HC Wainwright & Co. | Buy → Buy | $1 |
| 2025-04-10 | init | Mizuho | — → Outperform | $2 |
| 2025-03-05 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-11-15 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-08-14 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-03-11 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-11-14 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-08-15 | main | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-07-19 | init | Jefferies | — → Underperform | $1 |
| 2023-05-11 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2022-07-25 | main | HC Wainwright & Co. | — → Buy | $3 |
| 2021-08-19 | init | HC Wainwright & Co. | — → Buy | $6 |
| 2021-04-01 | down | SVB Leerink | Outperform → Market Perform | $3 |
- Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365 - Stock Titan Wed, 10 Jun 2026 12
- Implantable Eversense 365 shows 1-year diabetes control in real-world study - Stock Titan Sat, 06 Jun 2026 21
- Senseonics Holdings (SENS) price target decreased by 11.89% to 17.00 - MSN ue, 09 Jun 2026 01
- Senseonics (Nasdaq: SENS) completes Eversense CGM asset buys in key EU markets - Stock Titan Mon, 08 Jun 2026 20
- One-year implantable glucose monitor gets ADA 2026 oral presentation - Stock Titan Mon, 01 Jun 2026 07
- Senseonics (SENS) CMO granted 63,177 RSUs and options on 86,935 shares - Stock Titan hu, 21 May 2026 07
- Senseonics (SENS) director Sharon Larkin receives RSU and option grants - Stock Titan hu, 21 May 2026 07
- Senseonics (SENS) CEO awarded 553,701 RSUs and 761,923 stock options - Stock Titan hu, 21 May 2026 07
- Shareholders of Senseonics (NYSE: SENS) back charter change and 2026 equity plan - Stock Titan Wed, 20 May 2026 07
- A diabetes monitor that lasts a year reaches first patients in Sweden - Stock Titan Fri, 24 Apr 2026 07
- Senseonics (SENS) director Douglas Prince receives new equity awards - Stock Titan hu, 21 May 2026 07
- [Form 4] Senseonics Holdings, Inc. Insider Trading Activity - Stock Titan hu, 21 May 2026 07
- Equity grants to Senseonics (SENS) director add RSUs and options - Stock Titan hu, 21 May 2026 07
- Senseonics (SENS) director receives new RSU and stock option grants - Stock Titan hu, 21 May 2026 07
- Senseonics (NYSE: SENS) COO withholds 13,681 shares to cover tax obligations - Stock Titan Mon, 18 May 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
35.26
+56.89%
|
22.47
+0.37%
|
22.39
+36.62%
|
16.39
|
| Operating Revenue |
|
35.26
+56.89%
|
22.47
+0.37%
|
22.39
+36.62%
|
16.39
|
| Cost Of Revenue |
|
19.49
-11.14%
|
21.94
+13.68%
|
19.30
+41.25%
|
13.66
|
| Reconciled Cost Of Revenue |
|
19.49
-11.14%
|
21.94
+13.68%
|
19.30
+41.25%
|
13.66
|
| Gross Profit |
|
15.76
+2857.41%
|
0.53
-82.76%
|
3.09
+13.39%
|
2.73
|
| Operating Expense |
|
84.10
+11.58%
|
75.38
-4.22%
|
78.69
+10.29%
|
71.35
|
| Research And Development |
|
31.59
-23.22%
|
41.14
-15.61%
|
48.75
+22.74%
|
39.72
|
| Selling General And Administration |
|
52.51
+53.39%
|
34.23
+14.32%
|
29.94
-5.35%
|
31.63
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
—
|
| General And Administrative Expense |
|
—
|
—
|
—
|
—
|
| Other Gand A |
|
—
|
—
|
—
|
—
|
| Total Expenses |
|
103.59
+6.45%
|
97.31
-0.69%
|
97.99
+15.26%
|
85.02
|
| Operating Income |
|
-68.34
+8.69%
|
-74.84
+1.01%
|
-75.60
-10.17%
|
-68.63
|
| Total Operating Income As Reported |
|
-68.34
+8.69%
|
-74.84
+1.01%
|
-75.60
-10.17%
|
-68.63
|
| EBITDA |
|
-62.65
+8.81%
|
-68.70
-43.12%
|
-48.01
-129.67%
|
161.81
|
| Normalized EBITDA |
|
-62.65
+8.95%
|
-68.81
-0.06%
|
-68.76
-4.31%
|
-65.92
|
| Reconciled Depreciation |
|
1.51
+2.51%
|
1.48
+15.51%
|
1.28
+29.64%
|
0.98
|
| EBIT |
|
-64.16
+8.57%
|
-70.18
-42.40%
|
-49.28
-130.64%
|
160.82
|
| Total Unusual Items |
|
—
|
0.10
-99.51%
|
20.76
-90.89%
|
227.73
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.10
-99.51%
|
20.76
-90.89%
|
227.73
|
| Special Income Charges |
|
—
|
—
|
0.00
+100.00%
|
-0.24
|
| Other Special Charges |
|
—
|
—
|
—
|
0.10
|
| Write Off |
|
—
|
—
|
0.00
-100.00%
|
0.14
|
| Net Income |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Pretax Income |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Net Non Operating Interest Income Expense |
|
-0.75
+80.86%
|
-3.94
+31.54%
|
-5.75
+65.95%
|
-16.88
|
| Interest Expense Non Operating |
|
4.95
-41.32%
|
8.44
-24.06%
|
11.11
-40.60%
|
18.70
|
| Net Interest Income |
|
-0.75
+80.86%
|
-3.94
+31.54%
|
-5.75
+65.95%
|
-16.88
|
| Interest Expense |
|
4.95
-41.32%
|
8.44
-24.06%
|
11.11
-40.60%
|
18.70
|
| Interest Income Non Operating |
|
4.20
-6.75%
|
4.50
-16.04%
|
5.36
+193.97%
|
1.82
|
| Interest Income |
|
4.20
-6.75%
|
4.50
-16.04%
|
5.36
+193.97%
|
1.82
|
| Other Income Expense |
|
-0.02
-114.29%
|
0.16
-99.23%
|
20.96
-90.79%
|
227.62
|
| Other Non Operating Income Expenses |
|
-0.02
-138.98%
|
0.06
-70.79%
|
0.20
+298.04%
|
-0.10
|
| Gain On Sale Of Security |
|
—
|
0.10
-99.51%
|
20.76
-90.89%
|
227.97
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Net Income From Continuing Operation Net Minority Interest |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Net Income From Continuing And Discontinued Operation |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Net Income Continuous Operations |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Normalized Income |
|
-69.11
+12.20%
|
-78.72
+3.00%
|
-81.15
+5.21%
|
-85.61
|
| Net Income Common Stockholders |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Diluted EPS |
|
-1.66
+33.60%
|
-2.50
-2172.73%
|
-0.11
+0.00%
|
-0.11
|
| Basic EPS |
|
-1.66
+33.60%
|
-2.50
-2172.73%
|
-0.11
-136.67%
|
0.30
|
| Basic Average Shares |
|
41.73
-93.37%
|
629.72
+10.87%
|
567.97
+21.37%
|
467.95
|
| Diluted Average Shares |
|
41.73
-93.37%
|
629.72
+10.87%
|
567.97
-8.13%
|
618.21
|
| Diluted NI Availto Com Stockholders |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
+10.06%
|
-67.15
|
| Average Dilution Earnings |
|
—
|
—
|
0.00
+100.00%
|
-209.27
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
138.22
|
| Current Assets |
|
130.03
|
| Cash Cash Equivalents And Short Term Investments |
|
109.46
|
| Cash And Cash Equivalents |
|
75.71
|
| Cash Equivalents |
|
72.95
|
| Cash Financial |
|
2.76
|
| Other Short Term Investments |
|
33.75
|
| Receivables |
|
6.60
|
| Accounts Receivable |
|
4.53
|
| Gross Accounts Receivable |
|
4.53
|
| Taxes Receivable |
|
1.79
|
| Accrued Interest Receivable |
|
0.27
|
| Inventory |
|
8.78
|
| Raw Materials |
|
1.28
|
| Work In Process |
|
5.33
|
| Finished Goods |
|
2.16
|
| Prepaid Assets |
|
5.20
|
| Restricted Cash |
|
0.00
|
| Other Current Assets |
|
0.00
|
| Total Non Current Assets |
|
8.19
|
| Net PPE |
|
1.18
|
| Gross PPE |
|
3.67
|
| Accumulated Depreciation |
|
-2.48
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
3.14
|
| Other Properties |
|
—
|
| Leases |
|
0.53
|
| Goodwill And Other Intangible Assets |
|
0.00
|
| Other Intangible Assets |
|
—
|
| Investments And Advances |
|
0.00
|
| Non Current Prepaid Assets |
|
—
|
| Other Non Current Assets |
|
7.01
|
| Total Liabilities Net Minority Interest |
|
102.42
|
| Current Liabilities |
|
17.26
|
| Payables And Accrued Expenses |
|
11.55
|
| Payables |
|
4.57
|
| Accounts Payable |
|
4.57
|
| Current Accrued Expenses |
|
6.98
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
4.80
|
| Current Debt And Capital Lease Obligation |
|
0.37
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
0.37
|
| Other Current Liabilities |
|
0.03
|
| Total Non Current Liabilities Net Minority Interest |
|
85.17
|
| Long Term Debt And Capital Lease Obligation |
|
47.41
|
| Long Term Debt |
|
41.20
|
| Long Term Capital Lease Obligation |
|
6.21
|
| Other Non Current Liabilities |
|
—
|
| Preferred Securities Outside Stock Equity |
|
37.66
|
| Stockholders Equity |
|
35.80
|
| Common Stock Equity |
|
35.80
|
| Capital Stock |
|
0.53
|
| Common Stock |
|
0.53
|
| Share Issued |
|
530.36
|
| Ordinary Shares Number |
|
530.36
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
904.53
|
| Retained Earnings |
|
-869.26
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.01
|
| Other Equity Adjustments |
|
-0.01
|
| Total Equity Gross Minority Interest |
|
35.80
|
| Total Capitalization |
|
76.99
|
| Working Capital |
|
112.77
|
| Invested Capital |
|
76.99
|
| Total Debt |
|
47.78
|
| Net Debt |
|
—
|
| Capital Lease Obligations |
|
6.58
|
| Net Tangible Assets |
|
35.80
|
| Tangible Book Value |
|
35.80
|
| Current Notes Payable |
|
0.00
|
| Current Provisions |
|
0.51
|
| Derivative Product Liabilities |
|
0.10
|
| Duefrom Related Parties Current |
|
—
|
| Financial Assets |
|
—
|
| Interest Payable |
|
0.70
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-59.13
+2.21%
|
-60.47
+13.82%
|
-70.16
-5.81%
|
-66.31
|
| Cash Flow From Continuing Operating Activities |
|
-59.13
+2.21%
|
-60.47
+13.82%
|
-70.16
-5.81%
|
-66.31
|
| Net Income From Continuing Operations |
|
-69.11
+12.09%
|
-78.62
-30.18%
|
-60.39
-142.49%
|
142.12
|
| Depreciation Amortization Depletion |
|
1.51
+2.51%
|
1.48
+15.51%
|
1.28
+29.64%
|
0.98
|
| Depreciation |
|
—
|
1.48
+15.51%
|
1.28
+29.64%
|
0.98
|
| Depreciation And Amortization |
|
1.51
+2.51%
|
1.48
+15.51%
|
1.28
+29.64%
|
0.98
|
| Other Non Cash Items |
|
2.32
-42.83%
|
4.07
-45.73%
|
7.49
-38.42%
|
12.16
|
| Stock Based Compensation |
|
10.15
+10.06%
|
9.22
+6.36%
|
8.67
+0.64%
|
8.62
|
| Provisionand Write Offof Assets |
|
0.69
-82.39%
|
3.94
+2165.52%
|
0.17
|
0.00
|
| Asset Impairment Charge |
|
—
|
—
|
0.00
-100.00%
|
0.14
|
| Operating Gains Losses |
|
—
|
-0.10
+99.51%
|
-20.75
+90.89%
|
-227.87
|
| Gain Loss On Investment Securities |
|
—
|
-0.10
+98.47%
|
-6.65
+97.08%
|
-227.87
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
0.00
+100.00%
|
-14.11
|
0.00
|
| Change In Working Capital |
|
-3.28
-478.96%
|
0.86
+121.81%
|
-3.97
-60.50%
|
-2.47
|
| Change In Receivables |
|
-6.76
-150.65%
|
-2.70
-23.19%
|
-2.19
-358.37%
|
-0.48
|
| Changes In Account Receivables |
|
-6.76
-150.65%
|
-2.70
-23.19%
|
-2.19
-358.37%
|
-0.48
|
| Change In Inventory |
|
-2.98
-527.44%
|
0.70
+142.34%
|
-1.64
-66.23%
|
-0.99
|
| Change In Prepaid Assets |
|
1.47
-49.47%
|
2.90
+1151.09%
|
-0.28
+66.71%
|
-0.83
|
| Change In Payables And Accrued Expense |
|
5.93
+575.20%
|
0.88
-30.62%
|
1.27
+117.70%
|
0.58
|
| Change In Accrued Expense |
|
4.72
+74.25%
|
2.71
+362.82%
|
-1.03
-175.35%
|
1.37
|
| Change In Payable |
|
1.22
+166.63%
|
-1.83
-179.58%
|
2.30
+392.61%
|
-0.79
|
| Change In Account Payable |
|
1.22
+166.63%
|
-1.83
-179.58%
|
2.30
+392.61%
|
-0.79
|
| Change In Other Current Liabilities |
|
-0.94
-2.96%
|
-0.91
+18.72%
|
-1.12
-48.22%
|
-0.76
|
| Investing Cash Flow |
|
-53.42
-262.68%
|
32.84
-63.40%
|
89.71
+233.73%
|
26.88
|
| Cash Flow From Continuing Investing Activities |
|
-53.42
-262.68%
|
32.84
-63.40%
|
89.71
+233.73%
|
26.88
|
| Capital Expenditure |
|
-1.12
+50.16%
|
-2.24
-539.71%
|
-0.35
-12.18%
|
-0.31
|
| Capital Expenditure Reported |
|
-1.12
+50.16%
|
-2.24
-539.71%
|
-0.35
-12.18%
|
-0.31
|
| Net Investment Purchase And Sale |
|
-52.31
-249.12%
|
35.08
-61.05%
|
90.06
+231.19%
|
27.19
|
| Purchase Of Investment |
|
-100.69
-73.55%
|
-58.02
+15.35%
|
-68.54
+34.54%
|
-104.71
|
| Sale Of Investment |
|
48.39
-48.02%
|
93.09
-41.30%
|
158.60
+20.24%
|
131.90
|
| Financing Cash Flow |
|
78.19
+191.42%
|
26.83
+31.74%
|
20.37
-51.23%
|
41.76
|
| Cash Flow From Continuing Financing Activities |
|
78.19
+191.42%
|
26.83
+31.74%
|
20.37
-51.23%
|
41.76
|
| Net Issuance Payments Of Debt |
|
-20.40
-305.02%
|
9.95
+698.56%
|
1.25
+142.58%
|
-2.93
|
| Issuance Of Debt |
|
0.00
-100.00%
|
9.95
-59.30%
|
24.45
|
0.00
|
| Repayment Of Debt |
|
-20.40
|
0.00
+100.00%
|
-23.20
-692.89%
|
-2.93
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
9.95
-59.30%
|
24.45
|
0.00
|
| Long Term Debt Payments |
|
-20.40
|
0.00
+100.00%
|
-23.20
-692.89%
|
-2.93
|
| Net Long Term Debt Issuance |
|
-20.40
-305.02%
|
9.95
+698.56%
|
1.25
+142.58%
|
-2.93
|
| Net Common Stock Issuance |
|
100.59
+447.76%
|
18.36
+148.97%
|
7.38
-78.42%
|
34.17
|
| Proceeds From Stock Option Exercised |
|
0.14
-20.11%
|
0.18
-98.79%
|
14.77
+1262.64%
|
1.08
|
| Net Other Financing Charges |
|
-2.15
-29.10%
|
-1.66
+45.06%
|
-3.03
-17.78%
|
-2.57
|
| Changes In Cash |
|
-34.36
-4211.54%
|
-0.80
-102.00%
|
39.92
+1611.66%
|
2.33
|
| Beginning Cash Position |
|
74.91
-1.05%
|
75.71
+111.52%
|
35.79
+6.97%
|
33.46
|
| End Cash Position |
|
40.55
-45.87%
|
74.91
-1.05%
|
75.71
+111.52%
|
35.79
|
| Free Cash Flow |
|
-60.24
+3.92%
|
-62.70
+11.07%
|
-70.51
-5.84%
|
-66.62
|
| Interest Paid Supplemental Data |
|
4.05
-10.14%
|
4.51
+22.51%
|
3.68
-44.00%
|
6.57
|
| Amortization Of Securities |
|
-1.42
-7.73%
|
-1.32
+50.56%
|
-2.67
|
—
|
| Change In Interest Payable |
|
-0.49
-669.77%
|
0.09
+177.42%
|
0.03
+132.63%
|
-0.10
|
| Common Stock Issuance |
|
100.59
+447.76%
|
18.36
+148.97%
|
7.38
-78.42%
|
34.17
|
| Issuance Of Capital Stock |
|
100.59
+447.76%
|
18.36
+148.97%
|
7.38
-84.03%
|
46.17
|
| Net Preferred Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
12.00
|
| Preferred Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
12.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-06-08 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 42026-05-21 View
- 8-K2026-05-20 View
- 42026-05-18 View
- 42026-05-18 View
- 42026-05-18 View
- 42026-05-18 View
- 42026-05-18 View
- 42026-05-13 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|